MUMBAI, Nov 13 (Reuters) - Sun Pharmaceutical Industries Ltd , India’s largest drugmaker by revenue, reported a 15 percent jump in second-quarter net profit on Thursday, but slightly lagged estimates.
Net income for the quarter ended September was 15.72 billion rupees ($255.4 million), up from 13.62 billion rupees a year earlier. Analysts on average expected net income of 15.88 billion rupees, according to Thomson Reuters I/B/E/S.
Sun Pharma, which is in the process of acquiring rival drugmaker Ranbaxy Laboratories Ltd, is awaiting approval from India’s antitrust regulator for the deal. (1 US dollar = 61.5600 Indian rupee) (Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)